Similar Articles
341 Lean body mass index is a marker of advanced tumor features in patients with hepatocellular carcinoma
342 Comprehensive prognostic and immune analysis of sterol O-acyltransferase 1 in patients with hepatocellular carcinoma
343 Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis
344 Prognostic value of neutrophil-to-lymphocyte ratio in end-stage liver disease: A meta-analysis
345 Construction and validation of somatic mutation-derived long non-coding RNAs signatures of genomic instability to predict prognosis of hepatocellular carcinoma
346 Impact of frailty on short-term postoperative outcomes in patients undergoing colorectal cancer surgery: A systematic review and meta-analysis
347 Severe hypoxemia after radiofrequency ablation for atrial fibrillation in palliatively repaired tetralogy of Fallot: A case report
348 Efficacy and safety of bamlanivimab in patients with COVID-19: A systematic review and meta-analysis
349 Transarterial chemoembolization plus stent placement for hepatocellular carcinoma with main portal vein tumor thrombosis: A meta-analysis
350 MicroRNAs in hepatocellular carcinoma treatment: Charting the path forward
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA